Anavex Life Sciences Corp (AVXL)

[crescentmotor]

I don't see the company closing up shop if it doesn't get AD approval in Europe or a partner.

Agree and I didn't say it would happen overnight. I am giving you a view of the threats facing the company from 60,000 feet if 2-73 fails to be monetized. When internal development pipelines are disrupted, they must be rebuilt. Even if a company can reinvent its pipeline successfully, it can easily be a ten year process. Investors walk away and new investment capital can become non-existent. A company's stock price can languish at pitiful levels for multitudes of years. I don't expect the non-financial types here who haven't been exposed to the financial world and related strategic planning to see the potential picture I am painting. Even under a worse case scenario, I don't see AVXL's doors closing for years to come, perhaps never if company management remains frugal and makes the right decisions. But I can see a scenario where there is no financial reward for the company's stakeholders for years into the future. There is no question in my mind that the threats to financial viability are very real. The reality is that AVXL stock has been pummeled and is not attracting investors--only net selling as far as the eye can see. It is critical that 2-73 in AD must be successfully monetized over the next year through a third party partnership or by regulatory approval leading to commercial viability. I guarantee you Missling, as a financial guy with that training and experience, agrees with me.

Here's to approval of 2-73 for AD in Europe in 2024 or early 2025!!! Problems solved.